Skip to main content
S&P 5007,718.56-0.38%DOW53,419.10-0.50%NASDAQ26,490.82-0.35%BTC$79,565.00-1.85%ETH$2,450.30-1.93%GOLD$4,479.70-1.33%OIL$90.85-0.49%
Smart Investors Daily
Stryker Corporation logo

NYSE · SYK

Stryker Corporation

Healthcare · Medical - Devices

$307.99

Down-$2.50 (-0.81%)

Updated Sep 4, 2026, 3:19 PM

SID Score

5.5/10

Composite research score

Smart Money

46/100

Neutral

Market cap
134.97B
P/E ratio
45.86
Dividend yield
1.09%
52-week range
$281.00 – $389.33
Volume
2.66M
Avg. volume
1.61M

Price performance

SYK price history

1M range · 21 trading sessions · Daily adjusted prices

SYK closed at $307.99 after 21 trading sessions, down 8.72% for the selected period.

Last close
$307.99
Period change
-8.72%
Period low
$307.99
Period high
$348.15
Daily close
View OHLC price history
SYK OHLC price history, latest 40 sessions
DateOpenHighLowCloseVolume
Sep 3, 2026$313.96$319.50$306.50$307.992.66M
Sep 2, 2026$315.06$321.745$311.38$312.192.19M
Sep 1, 2026$329.83$331.50$316.85$317.402.14M
Aug 31, 2026$327.79$329.50$323.12$323.802.04M
Aug 28, 2026$322.61$332.72$322.12$330.692.23M
Aug 27, 2026$326.845$328.4499$321.60$322.122.17M
Aug 26, 2026$329.13$333.39$326.41$329.671.57M
Aug 25, 2026$325.09$331.75$324.00$330.592.2M
Aug 24, 2026$330.00$334.87$327.01$327.811.88M
Aug 21, 2026$326.03$332.55$324.00$329.453.16M
Aug 20, 2026$338.26$342.35$327.47$327.702.23M
Aug 19, 2026$331.74$343.90$331.00$339.982.19M
Aug 18, 2026$336.995$339.24$331.04$331.373.18M
Aug 17, 2026$338.00$339.76$331.30$331.682.29M
Aug 14, 2026$341.50$341.51$335.12$339.212.8M
Aug 13, 2026$345.02$346.64$339.53$341.092.02M
Aug 12, 2026$342.19$347.46$339.35$347.212.09M
Aug 11, 2026$344.45$349.765$344.45$348.151.63M
Aug 10, 2026$337.03$345.925$335.00$345.811.66M
Aug 7, 2026$336.67$340.00$332.5401$339.031.85M
Aug 6, 2026$340.45$343.87$334.24$337.431.8M

Latest SYK news

The latest Smart Investors Daily articles mentioning SYK.

Stock researchCompany · Overview

SYK research

Overview

Company profile and research snapshot.

Company profile

Stryker designs, manufactures, and markets an array of medical equipment, instruments, consumable supplies, and implantable devices. The product portfolio includes hip and knee replacements, extremities, endoscopy systems, operating room equipment, embolic coils, hospital beds and gurneys, and orthopedic robotics. Stryker remains one of the three largest competitors in reconstructive orthopedic implants and holds the leadership position in operating room equipment. Roughly one-fourth of Stryker's total revenue currently comes from outside the United States.

Visit company website

Analyst outlook

Consensus and target data currently published for this company.

Consensus
Buy
Average target
$419.33
Implied upside
—
Analysts
19
SYK recent ratings
DateFirmRatingTarget
Aug 13, 2026Wolfe ResearchPeer Perform—
Aug 3, 2026CitizensMarket Outperform—
Jul 31, 2026Truist SecuritiesHold—
Jul 31, 2026BTIGBuy—
Jul 31, 2026Piper SandlerOverweight—
Open full forecast

News briefing

No generated briefing is available yet.

Yahoo · Aug 21, 2026

US$100 Million Defense Contract Win Might Change The Case For Investing In Stryker (SYK)

Stryker’s sales unit in Michigan previously secured a US$100.00 million contract modification from the U.S. Defense Logistics Agency, underscoring its role as a key supplier to government healthcare and logistics systems. This award highlights the importance of stable government contracting as a complement to Stryker’s hospital and surgical product revenue mix. We’ll now examine how this sizable Defense Logistics Agency contract influences Stryker’s investment narrative, particularly its...

Yahoo · Aug 21, 2026

Stryker (SYK) Wins $100 Million Contract, Is It Still Below Fair Value?

Stryker (SYK) is back in focus after its Stryker Sales unit secured a $100 million contract modification from the US Defense Logistics Agency, a development that coincided with a 2.7% share price move. See our latest analysis for Stryker. For context, Stryker’s share price has been volatile around recent news, with a 4.17% 1 month share price return and a 5.88% decline year to date, while the 1 year total shareholder return is down 13.98%, the 3 year total shareholder return is up 23.40%, and...

Benzinga · Aug 21, 2026

Stryker Board Member Sold $117.78M In Company Stock

Ronda E Stryker, Board Member at Stryker (NYSE:SYK), reported an insider sell on August 20, according to a new SEC filing. What Happened: After conducting a thorough analysis, Stryker sold 350,000 shares of Stryker.

AI research layers

Interpretive context generated from the platform’s current data sources.

No results

AI research layers have not been published yet.

Featured By